The HCV pipeline efficacy and side effect of compounds in Phase 3 studies
20 February 2010. Related: Conference reports, Hepatitis coinfection.
Conference reports
12th European AIDS Society Conference (EACS) 11-14 November 2009, Cologne
31 December 2009. Related: Conference reports.
EACS releases three updated management guidelines (December 2009)
31 December 2009. Related: Conference reports, Guidelines.
11th International Workshop on Adverse Drug Reactions and Comorbidities in HIV (IWADR) 26-28 October 2009, Philadelphia
31 December 2009. Related: Conference reports.
Intermuscular tissue is decreased in HIV infection
31 December 2009. Related: Conference reports.
High incidence and risk factors for diabetes in French cohort
31 December 2009. Related: Conference reports.
Gender and race differences in lipodystrophy symptoms
31 December 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Lipodystrophy is common in children from three European cohorts
31 December 2009. Related: Conference reports, Paediatric care.
Visceral adipose tissue returns to baseline after stopping therapeutic intervention with rHGH
31 December 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Reduced levels of vitamin D in patients taking efavirenz
31 December 2009. Related: Conference reports.
Association between inflammation and sleep apnea in the MACS cohort
31 December 2009. Related: Conference reports.
Sports supplements impact on serum creatinine and eGFR markers of renal function
31 December 2009. Related: Conference reports.
9th AIDS Vaccine Conference 19-22 October 2009, Paris
31 December 2009. Related: Conference reports.
Thai HIV Vaccine Trial results presented and published
31 December 2009. Related: Conference reports, Vaccines and microbicides.
49th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12-15 September 2009, San Francisco
31 December 2009. Related: Conference reports.
Smoking masks the long-term benefits of HAART on lung function
31 December 2009. Related: Conference reports.
Recent ARVs and the blood/brain barrier: CSF drug concentrations of darunavir/r and raltegravir
31 December 2009. Related: Conference reports, Antiretrovirals.
Raltegravir body composition study: 48-week DEXA results
31 December 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Alcohol and marijuana may reduce drug levels of atazanavir and efavirenz
31 December 2009. Related: Conference reports, PK and drug interactions.
Other drug interaction studies at ICAAC
31 December 2009. Related: Conference reports, PK and drug interactions.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
30 December 2009. Related: Conference reports.
Early infant diagnosis
30 December 2009. Related: Conference reports, Paediatric care.
Difficulties with implementation
30 December 2009. Related: Conference reports, Paediatric care.
Infant outcomes
30 December 2009. Related: Conference reports, Paediatric care.
Improved neurodevelopmental outcomes
30 December 2009. Related: Conference reports, Paediatric care.
Treating children exposed to single dose nevirapine for PMTCT
30 December 2009. Related: Conference reports, Paediatric care.
Using a nevirapine-containing fixed dose combination in the CHAPAS trial
30 December 2009. Related: Conference reports, Paediatric care.
Once a day lamivudine and abacavir, and abacavir hypersensitivity in the ARROW trial
30 December 2009. Related: Conference reports, Paediatric care.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
5 October 2009. Related: Conference reports.
First results of new integrase compound: GSK1349572
5 October 2009. Related: Conference reports, Antiretrovirals.
Raltegravir in treatment-naive patients
5 October 2009. Related: Conference reports, Antiretrovirals.
Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study
5 October 2009. Related: Conference reports, Antiretrovirals.
Darunavir/r monotherapy studies
5 October 2009. Related: Conference reports, Antiretrovirals.
Maraviroc results similar to efavirenz when analysed using more sensitive tropism test
5 October 2009. Related: Conference reports, Antiretrovirals.
Lipid and metabolic changes with ARV combinations
5 October 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Maximal suppression achieved with three drugs: no additional virological impact of raltegravir intensification
5 October 2009. Related: Conference reports, Antiretrovirals.
Tenofovir and renal safety
5 October 2009. Related: Conference reports, Side effects.
Time from seroconversion to treatment in Europe and Africa
5 October 2009. Related: Conference reports.
Pharmacokinetics of atazanavir/ritonavir during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Presentation with late stage HIV in women diagnosed during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Low transmission rates and favourable pregnancy outcomes reported in the DREAM study
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy rates and outcomes among women in the DART trial
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy outcomes in HAART exposed infants in Johannesburg
5 October 2009. Related: Conference reports, Paediatric care.
Efavirenz conceptions in Soweto
5 October 2009. Related: Conference reports, Pregnancy.
Impact of regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg
5 October 2009. Related: Conference reports, Pregnancy.
A cost-effectiveness analysis of the OCTANE trial
5 October 2009. Related: Conference reports, Pregnancy.
The PEARL study
5 October 2009. Related: Conference reports, Pregnancy.
Results from HSV-2 acyclovir studies
5 October 2009. Related: Conference reports.
Overview of TB-related studies at IAS
5 October 2009. Related: Conference reports, TB coinfection.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
23 August 2009. Related: Conference reports.
Five-year survival rates of 87% without routine CD4 or laboratory monitoring in DART study demonstrate an important model for ARV access programmes
23 August 2009. Related: Conference reports, Treatment access.
Biomarkers associated with mortality: long-term follow up from SMART
23 August 2009. Related: Conference reports.
Update on Interleukin-2 clinical trials
23 August 2009. Related: Conference reports.
Influenza vaccine effective in HIV-positive adults
23 August 2009. Related: Conference reports.
Reducing HIV transmission during breastfeeding
23 August 2009. Related: Conference reports, Pregnancy.
Treating children previously exposed to single dose nevirapine
23 August 2009. Related: Conference reports, Paediatric care.
10th International Workshop on Clinical Pharmacology of HIV Therapy, 15-17 April 2009, Amsterdam
23 August 2009. Related: Conference reports.
Monotherapy study may explain previous poor clinical results when abacavir and tenofovir are used in combination
23 August 2009. Related: Conference reports, PK and drug interactions.
Interactions between ARVs and antimalarials atovaquone and proguanil
23 August 2009. Related: Conference reports, PK and drug interactions.
Four weeks lopinavir/r to cover functional monotherapy when stopping HAART
23 August 2009. Related: Conference reports, Antiretrovirals.
Efavirenz-related studies: genetics, smoking and TDM
23 August 2009. Related: Conference reports, Antiretrovirals.
Atazanavir: a suitable case for TDM?
23 August 2009. Related: Conference reports, Antiretrovirals.
Raltegravir PK in blood plasma and the genital tract
23 August 2009. Related: Conference reports.
A CYP2B6 haplotype influences nevirapine plasma concentrations following a single dose to reduce mother to child transmission
23 August 2009. Related: Conference reports, Pregnancy.
Population pharmacokinetic model of nevirapine maternal to infant transfer through breastfeeding
23 August 2009. Related: Conference reports, Paediatric care.